OFIX in the 13F filings
Orthofix Med Inc · CUSIP 68752M108
- Quarter end
- 31 Dec 2023
- the date the book describes
- Filed
- 14 Feb 2024
- latest of these filings; the earliest 8 Feb 2024
- Managers listing it
- 2
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2023 and Q4 2023; 1 listed it in both
- Shares listed
- 770,506
- combined, among listed positions
- Reported value
- $10m
- combined, at the quarter end
Among the 93 comparable managers: 1 buyer (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +104,959.
Managers listing OFIX in Q4 2023
2 of 2 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Glenview Capital Management LLC | 500,000 | $6.7m | 0.14% | New | new | 14 Feb 2024 (the filing on sec.gov) |
| ExodusPoint Capital Management LP | 270,506 | $3.6m | under 0.1% | Trimmed | -116,887 | 14 Feb 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Glenview Capital Management LLCnew position · 500,000 shares now+500,000
Reductions
- ExodusPoint Capital Management LPexisting position · 270,506 shares now-116,887
New positions and exits
New (1)
Exited (1)
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2018 | 4 | $40m | n.a. | n.a. |
| Q4 2018 | 5 | $42m | n.a. | n.a. |
| Q1 2019 | 4 | $48m | n.a. | n.a. |
| Q2 2019 | 5 | $49m | n.a. | n.a. |
| Q3 2019 | 5 | $45m | n.a. | n.a. |
| Q4 2019 | 3 | $18m | n.a. | n.a. |
| Q1 2020 | 3 | $12m | n.a. | n.a. |
| Q2 2020 | 3 | $19m | n.a. | n.a. |
| Q3 2020 | 2 | $14m | n.a. | n.a. |
| Q4 2020 | 3 | $29m | n.a. | n.a. |
| Q1 2021 | 3 | $27m | n.a. | n.a. |
| Q2 2021 | 3 | $15m | n.a. | n.a. |
| Q3 2021 | 3 | $14m | n.a. | n.a. |
| Q4 2021 | 3 | $9.8m | n.a. | n.a. |
| Q1 2022 | 3 | $12m | n.a. | n.a. |
| Q2 2022 | 3 | $13m | n.a. | n.a. |
| Q3 2022 | 2 | $14m | n.a. | n.a. |
| Q4 2022 | 3 | $14m | n.a. | n.a. |
| Q1 2023 | 2 | $1.9m | n.a. | n.a. |
| Q2 2023 | 2 | $13m | n.a. | n.a. |
| Q3 2023 | 2 | $8.6m | n.a. | n.a. |
| Q4 2023 | 2 | $10m | 1 | 2 |
| Q1 2024 | 2 | $15m | 2 | 0 |
| Q2 2024 | 2 | $17m | 2 | 0 |
| Q3 2024 | 2 | $3.4m | 0 | 1 |
| Q4 2024 | 1 | $2.7m | 1 | 1 |
| Q1 2025 | 1 | $2.6m | 1 | 0 |
| Q3 2025 | 1 | $2.5m | 1 | 0 |
| Q4 2025 | 1 | $2.6m | 10 | 10 |
| Q1 2026 | 1 | $2.3m | 15 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
OFIX and LLY →OFIX and JNJ →OFIX and VRTX →Choose a stock to compare with OFIX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own OFIX, latest filings →Back to the 13F Explorer →